Completed OBSERVATIONAL NCT00748384

Usability of the Foresee Home in Intermediate Age Related Macular Degeneration (AMD) Patients (UU2)

Usability of the Foresee Home in Intermediate Age Related Macular Degeneration Patients

Sponsor: Notal Vision Ltd.

Conditions Age Related Macular Degeneration

Updated 8 times since 2017 Last updated: May 14, 2013 Started: Feb 28, 2009 Primary completion: Mar 31, 2013 Completion: May 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Age Related Macular Degeneration, this trial is completed. The trial is conducted by Notal Vision Ltd. and has accumulated 8 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Dec 2020 — Jan 2021 [monthly]

Completed

▶ Show 3 earlier versions

Jun 2018 — Dec 2020 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Notal Vision Ltd.

Data source: Notal Vision Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kfar Saba, Israel
• Rehovot, Israel